83 related articles for article (PubMed ID: 8414504)
1. Expression of the TAL1 proto-oncogene in cultured endothelial cells and blood vessels of the spleen.
Hwang LY; Siegelman M; Davis L; Oppenheimer-Marks N; Baer R
Oncogene; 1993 Nov; 8(11):3043-6. PubMed ID: 8414504
[TBL] [Abstract][Full Text] [Related]
2. TAL1/SCL is expressed in endothelial progenitor cells/angioblasts and defines a dorsal-to-ventral gradient of vasculogenesis.
Drake CJ; Brandt SJ; Trusk TC; Little CD
Dev Biol; 1997 Dec; 192(1):17-30. PubMed ID: 9405094
[TBL] [Abstract][Full Text] [Related]
3. Products of the TAL1 oncogene: basic helix-loop-helix proteins phosphorylated at serine residues.
Cheng JT; Hsu HL; Hwang LY; Baer R
Oncogene; 1993 Mar; 8(3):677-83. PubMed ID: 8437851
[TBL] [Abstract][Full Text] [Related]
4. The TAL1/Scl basic helix-loop-helix protein blocks myogenic differentiation and E-box dependent transactivation.
Hofmann TJ; Cole MD
Oncogene; 1996 Aug; 13(3):617-24. PubMed ID: 8760303
[TBL] [Abstract][Full Text] [Related]
5. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
[TBL] [Abstract][Full Text] [Related]
6. TAL1, TAL2 and LYL1: a family of basic helix-loop-helix proteins implicated in T cell acute leukaemia.
Baer R
Semin Cancer Biol; 1993 Dec; 4(6):341-7. PubMed ID: 8142619
[TBL] [Abstract][Full Text] [Related]
7. Combinatorial effects of Flk1 and Tal1 on vascular and hematopoietic development in the mouse.
Ema M; Faloon P; Zhang WJ; Hirashima M; Reid T; Stanford WL; Orkin S; Choi K; Rossant J
Genes Dev; 2003 Feb; 17(3):380-93. PubMed ID: 12569129
[TBL] [Abstract][Full Text] [Related]
8. Assembly of the oncogenic DNA-binding complex LMO2-Ldb1-TAL1-E12.
Ryan DP; Duncan JL; Lee C; Kuchel PW; Matthews JM
Proteins; 2008 Mar; 70(4):1461-74. PubMed ID: 17910069
[TBL] [Abstract][Full Text] [Related]
9. The bHLH TAL-1/SCL regulates endothelial cell migration and morphogenesis.
Lazrak M; Deleuze V; Noel D; Haouzi D; Chalhoub E; Dohet C; Robbins I; Mathieu D
J Cell Sci; 2004 Mar; 117(Pt 7):1161-71. PubMed ID: 14970264
[TBL] [Abstract][Full Text] [Related]
10. Ets-1 regulates angiogenesis by inducing the expression of urokinase-type plasminogen activator and matrix metalloproteinase-1 and the migration of vascular endothelial cells.
Iwasaka C; Tanaka K; Abe M; Sato Y
J Cell Physiol; 1996 Dec; 169(3):522-31. PubMed ID: 8952701
[TBL] [Abstract][Full Text] [Related]
11. The SCL/TAL1 gene: roles in normal and malignant haematopoiesis.
Robb L; Begley CG
Bioessays; 1997 Jul; 19(7):607-13. PubMed ID: 9230693
[TBL] [Abstract][Full Text] [Related]
12. Tal1 transgenic expression reveals absence of B lymphocytes.
Palamarchuk A; Zanesi N; Aqeilan RI; Efanov A; Maximov V; Santanam U; Hagan JP; Croce CM; Pekarsky Y
Cancer Res; 2006 Jun; 66(12):6014-7. PubMed ID: 16778172
[TBL] [Abstract][Full Text] [Related]
13. Impairment of granulo-monocytic development of human common myeloid progenitors but not of granulo-monocytic progenitors by decreasing stem cell leukemia/T-cell acute leukemia 1 expression.
Brunet de la Grange P; Zink E; Armstrong F; Rouyez MC; Pflumio F
Stem Cells; 2008 Jun; 26(6):1658-62. PubMed ID: 18436863
[TBL] [Abstract][Full Text] [Related]
14. Antiapoptotic effect of ectopic TAL1/SCL expression in a human leukemic T-cell line.
Bernard M; Delabesse E; Novault S; Hermine O; Macintyre EA
Cancer Res; 1998 Jun; 58(12):2680-7. PubMed ID: 9635597
[TBL] [Abstract][Full Text] [Related]
15. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
[TBL] [Abstract][Full Text] [Related]
16. Association of a novel GTP binding protein, DRG, with TAL oncogenic proteins.
Mahajan MA; Park ST; Sun XH
Oncogene; 1996 Jun; 12(11):2343-50. PubMed ID: 8649774
[TBL] [Abstract][Full Text] [Related]
17. Transcription of the SCL gene in erythroid and CD34 positive primitive myeloid cells is controlled by a complex network of lineage-restricted chromatin-dependent and chromatin-independent regulatory elements.
Göttgens B; McLaughlin F; Bockamp EO; Fordham JL; Begley CG; Kosmopoulos K; Elefanty AG; Green AR
Oncogene; 1997 Nov; 15(20):2419-28. PubMed ID: 9395238
[TBL] [Abstract][Full Text] [Related]
18. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
[TBL] [Abstract][Full Text] [Related]
19. Enforced expression of PU.1 rescues osteoclastogenesis from embryonic stem cells lacking Tal-1.
Tsuneto M; Tominaga A; Yamazaki H; Yoshino M; Orkin SH; Hayashi S
Stem Cells; 2005; 23(1):134-43. PubMed ID: 15625130
[TBL] [Abstract][Full Text] [Related]
20. Coordinate expression of vascular endothelial growth factor receptor-1 (flt-1) and its ligand suggests a paracrine regulation of murine vascular development.
Breier G; Clauss M; Risau W
Dev Dyn; 1995 Nov; 204(3):228-39. PubMed ID: 8573716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
